AK

Anil Kumar

Active Director Director DIN 10044997
DIN 10044997 First appointment Feb 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Anil Kumar

Data last updated:

Anil Kumar is a Director at Friday Pharma Private Limited (since 2023). Friday Pharma Private Limited reported revenue of ₹38.1 Lakh (FY 2025).

DIN 10044997
Primary Designation Director
First Appointment 10 Feb 2023
Oldest Company Age 3 yrs
Largest company Friday Pharma Private Limited · ₹38.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Friday Pharma Private Limited U46691RJ2023PTC086007
Director10 Feb 20232023₹38.1 Lakh (FY 2025)Active

Board colleagues of Anil Kumar

NameDINCompanyDesignation
Baljinder Singh10044996Friday Pharma Private LimitedDirector
Bheem Singh10044998Friday Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Friday Pharma Private Limited
Premium access

Shareholding and investment profile for Anil Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kumar

Anil Kumar currently holds 1 directorship: Friday Pharma Private Limited (Director, since 10 Feb 2023, revenue ₹38.1 Lakh (FY 2025)).

Anil Kumar was first appointed on 10 Feb 2023 as Director at Friday Pharma Private Limited.

The current boards of Anil Kumar's companies include Baljinder Singh (Friday Pharma Private Limited), Bheem Singh (Friday Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available